AwardTape · Defense awards · Cellphire · Bodevet, Inc
Bodevet, Inc: -$212K in DoD and DHS awards (this registration)
This registration, Bodevet, Inc, holds 1 DoD and DHS prime award with -$212K obligated Jun 11, 2024 to Mar 10, 2025. Largest category: Science and technology R&D at -$212K; largest buyer: Defense Health Agency at -$212K.
| Obligated FY2024+ | -$212K |
|---|---|
| Awards | 1 |
| FY2024 | $0 |
| FY2025 | -$212K |
| FY2026 to date | $0 |
| Lifetime obligated on these awards | $2.5M |
| Parent company | Cellphire: $49.1M in DoD and DHS awards since FY2024 across 2 registrations |
| First and latest action | Jun 11, 2024 · Mar 10, 2025 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Science and technology R&D | -$212K | 1 awards | 100% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense Health Agency | -$212K | 1 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| W81XWH20C0067 definitive contract | -$212K | Clinical trial in support of trauma indications for lyophilized canine blood products | Defense Health Agency | Science and technology R&D | Mar 10, 2025 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial